Who owns CHINA SXT PHARMACEUTICALS IN?
- Ticker: SXTC
- CUSIP Number: g2161p157
Tip: Access positions for across all investors
Analyze quarterly positions in China Sxt Pharmaceuticals In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of China Sxt Pharmaceuticals In stock
Who bought or sold CHINA SXT PHARMACEUTICALS IN this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invesco | 85k | $137k | -5% | Dec 2025 |
|
| Geode Capital Management | 54k | $86k | 0% | Dec 2025 |
|
| Citadel Advisors | 49k | $78k | 100% | Sep 2025 |
|
| XTX Topco | 23k | $36k | 100% | Dec 2025 |
|
| Virtu Financial | 12k | $20k | -57% | Dec 2025 |
|
| Tower Research Capital | 1.8k | $2.9k | -37% | Dec 2025 |
|
| UBS Group | 222.00 | $356.088000 | 122% | Dec 2025 |
|
Who sold out of China Sxt Pharmaceuticals In?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Sep 2025 | 45k | $70k |
| Hrt Financial | Sep 2025 | 27k | $42k |
| Two Sigma Securities | Sep 2025 | 15k | $24k |